BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Menard M, Thümmler S, Giannitelli M, Cruzel C, Bonnot O, Cohen D, Askenazy F, Boublil M, Chambry J, Charvet D, Cseterky M, Fontas E, Fourneret P, Gicquel L, Kabuth B, Leroy B, Maria F, Moceri P, Parassol-girard N, Ravis B, Raynaud J, Roche J, Rochet T. Incidence of adverse events in antipsychotic-naïve children and adolescents treated with antipsychotic drugs: Results of a multicenter naturalistic study (ETAPE). European Neuropsychopharmacology 2019;29:1397-407. [DOI: 10.1016/j.euroneuro.2019.10.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Rice J, Ramtekkar U. Integrative Management of Metabolic Syndrome in Youth Prescribed Second-Generation Antipsychotics. Med Sci (Basel) 2020;8:E34. [PMID: 32824428 DOI: 10.3390/medsci8030034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Bulteau S, Le Pierres M, Artarit P, Forestier B, Michaud E, Chaslerie A, Bonnot O, Victorri-Vigneau C. Advocacy for better metabolic monitoring after antipsychotic initiation: based on data from a French health insurance database. Expert Opin Drug Saf 2021;20:225-33. [PMID: 33225754 DOI: 10.1080/14740338.2021.1851678] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Libowitz MR, Nurmi EL. The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children. Front Psychiatry 2021;12:623681. [PMID: 33776816 DOI: 10.3389/fpsyt.2021.623681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Varimo E, Aronen ET, Mogk H, Rättö H, Saastamoinen LK. Antipsychotic Treatment Duration in Children and Adolescents: A Register-Based Nationwide Study. J Child Adolesc Psychopharmacol 2021;31:421-9. [PMID: 33739863 DOI: 10.1089/cap.2020.0095] [Reference Citation Analysis]
5 Jeon SM, Park S, Kwon S, Kwon JW. Association Between Antipsychotic Treatment and Neurological Adverse Events in Pediatric Patients: A Population-Based Cohort Study in Korea. Front Psychiatry 2021;12:668704. [PMID: 34122182 DOI: 10.3389/fpsyt.2021.668704] [Reference Citation Analysis]
6 Rafaniello C, Sullo MG, Carnovale C, Pozzi M, Stelitano B, Radice S, Bernardini R, Rossi F, Clementi E, Capuano A. We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance Database. Front Psychiatry 2020;11:550201. [PMID: 33343407 DOI: 10.3389/fpsyt.2020.550201] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Raballo A, Poletti M, Preti A. Antipsychotics in Children and Adolescents at Clinical High Risk for Psychosis. J Am Acad Child Adolesc Psychiatry 2021:S0890-8567(21)00422-6. [PMID: 34224839 DOI: 10.1016/j.jaac.2021.05.025] [Reference Citation Analysis]
8 Stutzman DL. Long-term use of antidepressants, mood stabilizers, and antipsychotics in pediatric patients with a focus on appropriate deprescribing. Ment Health Clin 2021;11:320-33. [PMID: 34824957 DOI: 10.9740/mhc.2021.11.320] [Reference Citation Analysis]